vernamycin Ba, and PA114B) inhibited chloramphenicol binding to NH,Clwashed and native 70S ribosomes, but not to polyribosomes. After A large number of inhibitors of 50S ribosome function interfere with chloramphenicol binding to ribosomes (1, 7, 13, 19, 28) . These inhibitors include the macrolide antibiotics (erythromycin, angolamycin, carbomycin, spiramycin, lancamycin, methymycin, and oleandomycin), streptogramin A and B groups of antibiotics, lincomycin, celesticetin, sparsomycin, puromycin, and the amino nucleosides (amicetin, gougerotin, and blasticidin S). Most of these antibiotics are strong inhibitors of peptide bond formation as assayed by the use of washed ribosomes and model peptidyl donors such as acetyl-Phe-transfer ribonucleic acid (tRNA), fMet-tRNA, or polylysyl-tRNA (19) . More recent results evaluating the effects of these antibiotics on peptide bond formation on polyribosomes have indicated that, although many of these antibiotics are potent inhibitors of peptide bond formation in the model systems described above, the macrolide antibiotics, the streptogramins A and B, and the lincosaminides did not inhibit peptide bond formation on polyribosomes (20) . This suggested, therefore, that these antibiotics interact differently with ribosomes than with polyribosomes, and, although these antibiotics inhibited chloramphenicol binding to washed ribosomes, they may not be able to inhibit chloramphenicol binding to polyribosomes. It is likely that those antibiotics which 256 PESTKA cannot inhibit transpeptidation on polyribosomes but only with washed ribosomes must be interacting with the polyribosomes differently than with ribosomes, if they are interacting at all. The present studies were designed to investigate these differences.
Specifically, in this communication, the binding of chloramphenicol and erythromycin to ribosomes and polyribosomes is presented. In addition, the effects of anfibiotics on the binding of chloramphenicol to ribosomes and polyribosomes are reported. It is hoped that these studies should provide some insight into the structural or configurational differences between ribosomes and polysomes which produce these large differences in the effects of antibiotics.
MATERIALS AND METHODS
ANTIMICROB. AG [14C ]chloramphenicol. Unless otherwise specified, reaction mixtures were incubated at 24 C for 15 min. At the end of the incubation period, the reaction mixtures were diluted with ice-cold solution B and filtered through a type HAWP 25-mm diameter membrane filter (Millipore Corp.). The tube and filter were washed an additional two times with 3-ml portions of cold solution B. Filters were dried, and radioactivity bound to the filters was determined as described previously (17) .
Binding (14) . Ribosome and polyribosome preparations. The preparation of NH4Cl-washed ribosomes from Esche-RESULTS richia coli B was described previously (17 Upjohn; chlortetracycline was from American Cyana-binding to ribosomes and polyribosomes. mid; and neomycin was from Nutritional Biochemi-There was a decrease in chloramphenicol bindcals. Other antibiotics were obtained from the sources ing to ribosomes and polyribosomes from about previously indicated (9, 18, 22) .
[14C]Chloram-1 to 20 mM Mg2+ (Fig. 2) . This decrease was phenicol (13. 3 Ci/mol) was obtained from New Eng-slight for polyribosomes, but rather substantial land Nuclear Corp. ["C]Erythromycin (8.29 Ci/mol)foNHC-ahdrbsmsAt2mM g+ was a gift from J. C.-H. Mao 24 c These antibiotics were dissolved in dimethylsulfoxide to give 0.01 M solutions. Further dilutions were made in water.
d Micrococcin was dissolved in 37% ethanol to give a 0.01 M solution; further dilutions were made in water. Molecular weight of micrococcin was taken as 2,290 (S. Pestka, In Antibiotics: mode of action, vol. 2, in press).
Sparsomycin inhibited chloramphenicol binding to these NH,Cl-washed ribosomes slightly, if at all, at very high concentrations only. In contrast, sparsomycin inhibited transpeptidation and C-A-C-C-A(Phe) binding to ribosomes substantially at concentrations lower than 10 AM (8, 16, 18, 19 Thiostrepton and micrococcin had no effect on chloramphenicol binding to polyribosomes. Effect of antibiotics on ['4Cehbloramphen-icol binding to puromycin-treated polyribosomes. Since it appeared that the treatment of polyribosomes with puromycin that reacted with peptidyl-tRNA increased the binding of erythromycin to these polyribosomes, it was speculated that the removal of the peptidyl moiety from peptidyl-tRNA would permit the macrolide, lincosaminide, and streptogramin antibiotics to bind to the ribosome monomers more effectively. Thus, the effect of antibiotics on chloramphenicol binding to puromycintreated polyribosomes was examined (Table 7) . After puromycin treatment, the macrolide, streptogramin, and amino nucleoside antibiotics significantly inhibited ['IC ]chloramphenicol binding to polyribosomes (Table 7) . Their inhibition of binding of chloramphenicol to puromycin-treated polyribosomes is similar to their inhibition of binding to NH4Cl-washed or native 70S ribosomes. It should be noted -that methymycin inhibited chloramphenicol binding to polyribosomes slightly (Table 2) . Methymycin, being one of the smallest macrolide antibiotics, appears therefore to be able to enter an appropriate site for inhibition of chloramphenicol binding even in the presence of peptidyl-tRNA. However, when peptidyl-tRNA is removed, its inhibition of binding is somewhat increased. The lack of complete conversion of the polyribosomes to behavior as 70S ribosomes after puromycin treatment may be ascribed to the incomplete removal of peptidyl-tRNA by puromycin under these conditions. Lincomycin and celesticetin inhibited binding of chloramphenicol to these puromycin-treated polyribosomes similar to their inhibition of binding to NH4Cl-washed ribosomes.
The binding of chloramphenicol to puromycin-treated polyribosomes became largely insensitive to sparsomycin and althiomycin (compare Tables 2 and 7 , and Fig. 3.) . Thus, the removal of peptidyl-tRNA from polyribosomes apparently decreased the sensitivity of chloramphenicol binding to sparsomycin and althiomycin.
Effect of antibiotic combinations on chloramphenicol binding. From the foregoing results it appeared that the presence of peptidyltRNA on polyribosomes prevented most of the Upon removal of peptidyl-tRNA, neither sparsomycin nor althiomycin could effectively inhibit chloramphenicol binding to the puromycin-treated polyribosomes. Although these were the implications of the results, the data were not so precise, for there was always some residual binding of chloramphenicol to ribosomes in the presence of the macrolides, lincosaminides, and streptogramins, and always some residual binding of chloramphenicol to polyribosomes in the presence of sparsomycin or althiomycin. Since large quantities of native 70S ribosomes and polyribosomes were required for these binding studies, it was conceivable that contamination of the fractions could account for the lack of complete inhibitions. Indeed, sedimentation analysis of the native 70S ribosomes and polyribosomes showed 10 to 20% contamination by polyribosomes and 70S ribosomes, respectively. Thus, if the residual chloramphenicol binding were due to the presence of species resistant to the antibiotic, it could explain the lack of complete inhibition by the appropriate antibiotics. For these reasons, several of the antibiotics were evaluated in combination.
The effects of 0.1 mM erythromycin and sparsomycin on [4C ]chloramphenicol binding to polyribosomes are shown in Table 8 . Erythromycin alone produces a 28% inhibition of binding; sparsomycin alone produces a 75% inhibition. The inhibition is additive so that together they produce almost complete inhibition (93%) of chloramphenicol binding to polyribosomes. These results are consistent with the hypothesis that the residual binding of chloramphenicol to polyribosomes in the presence of 0.1 mM sparsomycin is due to the presence of native 70S ribosomes in the polyribosome preparation. somes and for transpeptidation (18, 19, 24) . In contrast, neither polyribosomes nor native 70S ribosomes require high K+ for chloramphenicol binding to ribosomes, and, in fact, transpeptidation with polyribosomes also requires only minimal levels of K+ (10 to 50 mM) (21) .
It is evident from the data of Tables 1, 2 , and 4 that the macrolide and streptogramin antibiotics, which have been considered to be potent inhibitors of chloramphenicol binding as well as transpeptidation with washed ribosomes, do not inhibit chloramphenicol binding to polyribosomes. Upon the removal of peptidyl-tRNA from the polyribosomes, these antibiotics once again can inhibit chloramphenicol binding ( Table 7) . The results with the lincosaminides are probably similar, although not as dramatic, since lincomycin and celesticetin are not as effective inhibitors of chloramphenicol binding or transpeptidation with E. coli ribosomes. Since neither the macrolide, the streptogramin, nor lincosaminide antibiotics inhibit transpeptidation on polyribosomes (20) , it may be concluded that these antibiotics do not bind effectively to the ribosome monomers of polyribosomes. Only after peptidyl-tRNA is removed do these antibiotics subsequently bind and inhibit chloramphenicol binding. Methymycin may be an exception. It is one of the smallest macrolide antibiotics and produces a slight inhibition of transpeptidation on polyribosomes (20) . It also inhibits chloramphenicol binding to polyribosomes (Table 2) . Thus, these results suggest that the large size of the macrolides and the streptogramins prevents them from binding to ribosomes when peptidyl-tRNA is attached. The smaller macrolide methymycin, lincomycin, and celesticetin can apparently attach to polyribosomes, for they inhibit chloramphenicol binding to polyribosomes. However, on interacting with polyribosomes, methymycin and lincomycin appear to inhibit transpeptidation substantially less than chloramphenicol binding (Table 2 and reference 20) . Therefore, it seems that inhibition of transpeptidation and chloramphenicol binding may not involve identical sites or interactions. Nevertheless, since methymycin can interact with polyribosomes, it might be expected that it would have a greater stabilizing effect on polyribosomes than the other macrolide antibiotics. Also, it is conceivable that the effect of macrolides on chain elongation may be a function of their ring size.
It has been considered that the macrolide and the streptogramin antibiotics are antagonistic to chloramphenicol because of their mutual interference with chloramphenicol binding to (2) and Ennis (4, 5) reported that some of these macrolides (carbomycin, leucomycin, spiramycin, and tylosin) and streptogramin A antibiotics (vernamycin A and PA114A) in fact do not inhibit protein synthesis during chain elongation on polyribosomes, for polyribosomes break down rapidly into ribosome monomers in their presence. It is likely, therefore, that these antibiotics may be inhibiting protein synthesis during an early step in chain elongation or during one of the initiation events. In any case, then, these antibiotics are not likely to be antagonistic to chloramphenicol throughout chain elongation during most of the time ribosomes are within the polysomal structure. The data with regard to erythromycin and oleandomycin are not as clear to interpret, for these macrolides have been reported to inhibit chain elongation and stabilize polyribosomes (3, 5) . The suggestion has been made that erythromycin is an inhibitor of translocation (3, 11, 19 press]) have no effect on chloramphenicol binding to ribosomes or polyribosomes. They both inhibit translocation (22) , but not transpeptidation (20) . Since these antibiotics do not inhibit transpeptidation or any reactions related to it such as C-A-C-C-A(Phe) binding to ribosomes, it was not expected that they should inhibit chloramphenicol binding to ribosomes.
Chlortetracycline is predominantly a 30S inhibitor (19) . At much higher concentrations, 50S reactions can be inhibited. It can be seen that a concentration of 0.1 mM chlortetracycline could inhibit chloramphenicol binding to ribosomes, but not to polyribosomes. At 1 mM, chlortetracycline can inhibit chloramphenicol binding to ribosomes and perhaps also to polyribosomes. It seems, therefore, that chlortetracycline can perturb the structure of ribosomes more easily than it can perturb the structure of polyribosomes. Neomycin is also chiefly a 30S inhibitor. However, inhibition of transpeptidation by neomycin has been reported with the use of cell-free systems from both E. coli and rat liver (20, 25) . It had very little effect on chloramphenicol binding to either ribosomes or polyribosomes.
The striking increase in sensitivity of chloramphenicol binding to polyribosomes to the antibiotics sparsomycin and althiomycin is another observation in support of the idea that the state of the ribosome monomers of polyribosomes differ significantly from those of NH4Cl-washed or native 70S ribosomes. On treatment with puromycin, polyribosomes lose their sensitivity to sparsomycin and althiomycin. It is possible that the presence of peptidyl-tRNA on the ribosome monomers of polyribosomes stabilizes the binding of both sparsomycin and althiomycin. In this regard, it is noteworthy that Hemer et al. (10) reported that sparsomycin stabilizes the binding of peptidyltRNA to ribosomes. Furthermore, these conclusions are consistent with the findings of Tada and Trakatellis (26) , who showed that [5H Isparsomycin does not bind to ribosomes. Only in the presence of the 100,000 x g supernatant or poly U and acetyl-phenylalanyl-tRNA did ribosomes bind [3H Isparsomycin.
The observation that the macrolides and streptogramins inhibit ["C ]chloramphenicol binding to native 70S ribosomes and 50S subunits, but not to polyribosomes, can be used as an assay for the percent of native polyribosomes in crude extracts or polyribosome preparations. Analogously, the observation that sparsomycin and althiomycin inhibit [4C ]chloramphenicol binding to polyribosomes, but not to ribosomes or 50S subunits, can similarly be employed as an assay for these constituents.
To integrate our knowledge of the effects of antibiotics on intact cells and their effects on cell-free systems, it is necessary to use cell-free systems which reflect physiological conditions. Apparently, as has been noted in previous reports (2, 4, (19) (20) (21) , many results in cell-free systems on transpeptidation do not correlate with effects of antibiotics on intact cells. One of the reasons for these differences is that cell-free assays for transpeptidation which utilize NH4Cl-washed ribosomes do not necessarily reflect the state and susceptibility of the ribosome monomers of polyribosomes which exist under physiological conditions of protein synthesis. The results presented in this communication clarify some of these differences and should allow a better understanding of the relationship of the effects of antibiotics in cell-free systems and their effects on intact organisms.
